Back
Catalyst Pharmaceuticals 10K Form
Buy
57
CPRX
Catalyst Pharmaceuticals
Last Price:
21.95
Seasonality Move:
-2.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CPRX News And Ratings
See the #1 stock for the next 7 days that we like better than CPRX
CPRX Financial Statistics
Sales & Book Value
| Annual Sales: | $398.2M |
|---|---|
| Cash Flow: | $64.13M |
| Price / Cash Flow: | 22.37 |
| Annual Sales: | $5.14 |
| Price / Book: | 4.28 |
Profitability
| EPS (TTM): | 0.54000 |
|---|---|
| Net Income (TTM): | $68.15M |
| Gross Margin: | $346.24M |
| Return on Equity: | 14.93% |
| Return on Assets: | 12.71% |
Catalyst Pharmaceuticals Earnings Forecast
Key Catalyst Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
- The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
- The Research & Development expenses have been 23.39% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 22 years have been positive in 10 years.
Catalyst Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CPRX |
| CUSIP: | 14888U |
| Website: | catalystpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.14 |
| Quick Ratio: | 4.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 34.86 |
|---|---|
| Forward P/E Ratio: | 10.23 |
CPRX Technical Analysis vs Fundamental Analysis
Buy
57
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Buy
The current Catalyst Pharmaceuticals [CPRX] share price is $21.96. The Score for CPRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.